Search results for "PREDICT"

showing 10 items of 2174 documents

Development and external validation of a clinical prediction model for functional impairment after intracranial tumor surgery

2021

OBJECTIVE Decision-making for intracranial tumor surgery requires balancing the oncological benefit against the risk for resection-related impairment. Risk estimates are commonly based on subjective experience and generalized numbers from the literature, but even experienced surgeons overestimate functional outcome after surgery. Today, there is no reliable and objective way to preoperatively predict an individual patient’s risk of experiencing any functional impairment. METHODS The authors developed a prediction model for functional impairment at 3 to 6 months after microsurgical resection, defined as a decrease in Karnofsky Performance Status of ≥ 10 points. Two prospective registries in…

AdultMaleMicrosurgerymedicine.medical_specialtyFunctional impairmentAdolescentIntracranial tumorNerve manipulationoutcome predictionYoung Adult03 medical and health sciencesPostoperative Complications0302 clinical medicinePredictive Value of TestsHumansMedicineGeneralizability theoryneurosurgeryProspective StudiesRegistriesKarnofsky Performance StatusAgedRetrospective StudiesAged 80 and overBrain Neoplasmsbusiness.industryExternal validationArea under the curveReproducibility of ResultsGeneral MedicineMiddle AgedSurgerypredictive analyticsmachine learningfunctional impairment030220 oncology & carcinogenesisoncologyCohortFemaleNeurosurgerybusiness030217 neurology & neurosurgeryJournal of Neurosurgery
researchProduct

Accuracy of the fetal cerebroplacental ratio for the detection of intrapartum compromise in nonsmall fetuses

2018

Objective: To study the accuracy of the cerebroplacental ratio (CPR) for the detection of intrapartum fetal compromise (IFC) in fetuses growing over the 10th centile.Methods: This was a prospective...

AdultMaleMiddle Cerebral Arterymedicine.medical_specialtyeducationGestational AgeFetal DistressUltrasonography PrenatalUmbilical Arteries03 medical and health sciences0302 clinical medicinePredictive Value of TestsPregnancymedicineFetal growthBirth WeightHumansProspective Studies030212 general & internal medicinereproductive and urinary physiologyFetus030219 obstetrics & reproductive medicineObstetricsbusiness.industryInfant NewbornPregnancy OutcomeReproducibility of ResultsObstetrics and GynecologyFetal dopplerPulsatile Flowembryonic structuresPediatrics Perinatology and Child HealthFemalebusinessThe Journal of Maternal-Fetal & Neonatal Medicine
researchProduct

Direct visualization of oral-cavity tissue fluorescence as novel aid for early oral cancer diagnosis and potentially malignant disorders monitoring.

2011

Direct visualization of the oral tissue autofluorescence has been recently reviewed in several studies as a possible adjunctive tool for early recognition and diagnosis of potentially malignant and malignant oral disorders. The aims of this study were to assess: a) the value of a simple handheld device for tissue auto-fluorescence visualization of potentially malignant oral lesions; and b) the sensitivity, specificity and diagnostic accuracy of tested device, using histological examination as the gold standard. 175 consecutive patients, with at least one clinical oral lesion, were enrolled in the study. Clinical conventional inspections were performed for each patient by two blind operator…

AdultMaleMild DysplasiaPathologymedicine.medical_specialtyEpithelial dysplasiaImmunologySettore MED/50 - Scienze Tecniche Mediche ApplicateautofluorescenceFluorescenceYoung Adultoral lichen planusPredictive Value of TestsOPMD fluorescenceSettore MED/28 - Malattie OdontostomatologicheBiopsyepithelial dysplasiamedicineHumansImmunology and AllergyEarly Detection of CancerAgedLeukoplakiaAged 80 and overPharmacologyMouthmedicine.diagnostic_testbusiness.industryDiagnosis OralMiddle Agedoral cancermedicine.diseaseautofluorescence; epithelial dysplasia; leukoplakia; oral cancer; oral lichen planus;stomatognathic diseasesDysplasialeukoplakiaFemaleMouth NeoplasmsHistopathologyOral lichen planusbusinessPrecancerous ConditionsOral medicine
researchProduct

Visual inference of arm movement is constrained by motor representations

2015

International audience; Several studies support the idea that motion inference is strongly motor dependent. In the present study, we address the role of biomechanical constraints in motion prediction and how this implicit knowledge can interfere in a spatial prediction task. Right-handed (RHS) and left-handed subjects (LHS) had to estimate the final position of a horizontal arm movement in which the final part of the trajectory was hidden. Our study highlighted a direction effect: end point prediction accuracy was better to infer the final position of horizontal motion directed toward the median line of human body. This finding suggests that the spatial prediction of end point is mapped ont…

AdultMaleMotion PerceptionInferenceMotor Activity050105 experimental psychologyMotion (physics)Task (project management)Young Adult03 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePosition (vector)motionMotor systemHumansdewey1500501 psychology and cognitive sciencesComputer visionBiomechanical constraintsMovement (music)business.industry05 social sciencesspacepredictionMotor systembodyBiomechanical PhenomenaSpatial predictionEmbodied cognitionSpace Perception[ SDV.NEU ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]ArmVisual PerceptionTrajectoryFemale[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Artificial intelligencebusinessPsychomotor Performancepsychological phenomena and processes030217 neurology & neurosurgery
researchProduct

Quantifying Net Synergy/Redundancy of Spontaneous Variability Regulation via Predictability and Transfer Entropy Decomposition Frameworks.

2017

Objective: Indexes assessing the balance between redundancy and synergy were hypothesized to be helpful in characterizing cardiovascular control from spontaneous beat-to-beat variations of heart period (HP), systolic arterial pressure (SAP), and respiration (R). Methods: Net redundancy/synergy indexes were derived according to predictability and transfer entropy decomposition strategies via a multivariate linear regression approach. Indexes were tested in two protocols inducing modifications of the cardiovascular regulation via baroreflex loading/unloading (i.e., head-down tilt at −25° and graded head-up tilt at 15°, 30°, 45°, 60°, 75°, and 90°, respectively). The net redundancy/synergy of …

AdultMaleMultivariate statisticsComputer scienceEntropyBiomedical EngineeringBlood Pressurecomputer.software_genreAutonomic Nervous System01 natural sciences010305 fluids & plasmasHead-Down TiltEntropy (classical thermodynamics)ElectrocardiographyYoung AdultHeart RateBayesian multivariate linear regression0103 physical sciencesStatisticshead-down tilt (HDT)Redundancy (engineering)Entropy (information theory)HumansPredictabilityEntropy (energy dispersal)010306 general physicsEntropy (arrow of time)cardiovascular controlModels StatisticalEntropy (statistical thermodynamics)heart rate variabilityUnivariateSignal Processing Computer-AssistedBaroreflexMiddle Agedhead-up tilt (HUT)Settore ING-INF/06 - Bioingegneria Elettronica E InformaticaTransfer entropyFemaleData miningWiener-Granger causalitycomputerEntropy (order and disorder)IEEE transactions on bio-medical engineering
researchProduct

The Use of Acoustic Rhinometry in Predicting Outcomes after Sinonasal Surgery

2000

Today's healthcare environment demands objective assessment of surgical outcomes. The recent otolaryngologic literature has established acoustic rhinometry (AR) as a valid instrument to objectively document nasal patency. The purpose of this article is to evaluate the utility of AR in predicting outcomes after sinonasal surgery. All patients scheduled for sinonasal surgery at the Tulane University and University of Mainz Departments of Otolaryngology between 10/1/98 and 12/15/98 were enrolled. All subjects underwent AR and completed a sinonasal outcome survey (SNOT-20) one day before and two months after their surgical procedure. Thirty-one patients were enrolled. The SNOT-20 raw scores im…

AdultMaleNasal cavitymedicine.medical_specialtyManometryObjective assessment03 medical and health sciencesSubjective improvement0302 clinical medicineAcoustic rhinometryPredictive Value of TestsParanasal SinusesmedicineHumansRaw score030223 otorhinolaryngologybusiness.industryMean valueSurgeryTreatment Outcomemedicine.anatomical_structureOtorhinolaryngologyOtorhinolaryngology030220 oncology & carcinogenesisFemalebusinessAmerican Journal of Rhinology
researchProduct

Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer Patients

2004

Abstract Purpose: No chemotherapy regimen, including the widely used combination of gemcitabine/cisplatin, confers significantly improved survival over any other in metastatic non-small cell lung cancer (NSCLC); however, the selection of patients according to key genetic characteristics can help to tailor chemotherapy. Ribonucleotide reductase subunit M1 (RRM1) is involved in DNA synthesis and repair and in gemcitabine metabolism, and the excision repair cross-complementing group 1 (ERCC1) gene has been related to cisplatin activity. Experimental Design: Patients were part of a large randomized trial carried out from September 1998 to July 2000, comparing gemcitabine/cisplatin versus gemcit…

AdultMaleOncologyAntimetabolites AntineoplasticCancer Researchmedicine.medical_specialtyPathologyLung NeoplasmsTime FactorsDNA RepairRibonucleoside Diphosphate Reductasemedicine.medical_treatmentAntineoplastic AgentsBiologyVinorelbineDeoxycytidineCarcinoma Non-Small-Cell LungInternal medicineRibonucleotide ReductasesmedicineHumansRNA MessengerLung cancerAgedCisplatinChemotherapyPredictive markerTumor Suppressor ProteinsDNAMiddle AgedEndonucleasesPrognosismedicine.diseaseGemcitabineChemotherapy regimenGemcitabineDNA-Binding ProteinsTreatment OutcomeOncologyFemaleCisplatinERCC1medicine.drugClinical Cancer Research
researchProduct

The clinical value of tumor burden at diagnosis in Hodgkin lymphoma

2004

BACKGROUND The authors investigated the clinical role of tumor burden (TB) in patients with Hodgkin lymphoma, relating this parameter to most of the current clinical and prognostic factors and to the best predictive multifactorial models. METHODS The volume of TB at diagnosis was measured directly from the initial staging computed tomography scans in 351 patients who were treated on standard protocols. The mean patient age was 34.0 years ± 16.4 years. Forty-six patients had clinical Stage I disease, 201 patients had Stage II disease, 64 patients had Stage III disease, and 40 patients had Stage IV disease. There were 146 symptomatic patients. Overall survival (OS), disease-free survival (DFS…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyTime FactorsMultivariate analysisAdolescentBody Surface AreaDiseaseLogistic regressionText miningPredictive Value of TestsInternal medicineBiomarkers TumormedicineHumansTreatment FailureStage (cooking)Neoplasm StagingRetrospective StudiesBody surface areabusiness.industryRemission InductionCancerMiddle AgedPrognosismedicine.diseaseHodgkin DiseaseSurgeryLymphomaSurvival RateOncologyFemaleTomography X-Ray ComputedbusinessCancer
researchProduct

Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease

2014

Chronic obstructive pulmonary disease (COPD) and lung cancer are widespread lung diseases. Cigarette smoking is a high risk factor for both the diseases. COPD may increase the risk of developing lung cancer. Thus, it is crucial to be able to distinguish between these two pathological states, especially considering the early stages of lung cancer. Novel diagnostic and monitoring tools are required to properly determine lung cancer progression because this information directly impacts the type of the treatment prescribed. In this study, serum samples collected from 22 COPD and 77 lung cancer (TNM stages I, II, III, and IV) patients were analyzed. Then, a collection of NMR metabolic fingerprin…

AdultMaleOncologymedicine.medical_specialtyLung NeoplasmsMagnetic Resonance SpectroscopyClinical BiochemistryPharmaceutical ScienceCreatineAnalytical ChemistryDiagnosis DifferentialPulmonary Disease Chronic Obstructivechemistry.chemical_compoundPredictive Value of TestsCarcinoma Non-Small-Cell LungInternal medicineDrug DiscoveryBiomarkers TumormedicineHumansMetabolomicsLeast-Squares AnalysisRisk factorLung cancerLungPathologicalEarly Detection of CancerSpectroscopyAgedNeoplasm StagingAged 80 and overUnivariate analysisCOPDLungChemistryDiscriminant AnalysisMiddle AgedPrognosismedicine.diseaserespiratory tract diseasesmedicine.anatomical_structureMultivariate AnalysisDisease ProgressionFemaleLung cancer stagingJournal of Pharmaceutical and Biomedical Analysis
researchProduct

PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline-based first line therapy

2012

Soft tissue sarcomas are aggressive tumors representing <1% of all adult neoplasms. Aim of our study was to evaluate promyelocytic leukemia gene expression value as prognostic factor and as a factor predicting response to alkylating agents/antracycline-based first line therapy. One hundred eleven patients affected by locally advanced and metastatic soft tissue sarcoma were selected. PML expression was evaluated by immunohistochemical analysis in pathological samples and in the corresponding normal tissue from each case. PML immunohistochemical results were correlated with prognosis and with radiological response to alkylating agents/antracycline-based first line therapy. PML expression was …

AdultMaleOncologymedicine.medical_specialtySettore MED/06 - Oncologia MedicaPhysiologyClinical BiochemistryCellDown-RegulationSoft Tissue NeoplasmsPromyelocytic Leukemia ProteinLiposarcomaPleomorphic LiposarcomaYoung AdultPredictive Value of TestsInternal medicinemedicineHumansAnthracyclinesAntineoplastic Agents AlkylatingPathologicalAgedRetrospective StudiesAged 80 and overPMLbusiness.industryTumor Suppressor ProteinsSoft tissue sarcomaNuclear ProteinsSoft tissueSarcomaCell BiologyMiddle AgedPrognosismedicine.diseaseImmunohistochemistrymedicine.anatomical_structuresoft tissue sarcomas; PMLDrug Resistance Neoplasmsoft tissue sarcomaImmunologyImmunohistochemistryFemaleSarcomabusinessTranscription Factors
researchProduct